Detalhe da pesquisa
1.
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.
Cancer Immunol Immunother
; 72(12): 4195-4207, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848682
2.
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities.
Curr Opin Oncol
; 34(5): 552-558, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880455
3.
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Cancer Metastasis Rev
; 39(3): 969-987, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507912
4.
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs.
J Virol
; 92(14)2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720517
5.
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.
Blood
; 123(3): 356-65, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24300852
6.
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.
Blood
; 119(26): 6226-33, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22592608
7.
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
Blood
; 120(26): 5185-7, 2012 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23024237
8.
CD19-directed T cell-engaging antibodies for the treatment of autoimmune disease.
J Exp Med
; 221(5)2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587494
9.
CLN-617 retains IL-2 and IL-12 in injected tumors to drive robust and systemic immune-mediated antitumor activity.
Cancer Immunol Res
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842347
10.
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.
Liver Int
; 33(1): 127-36, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23088518
11.
T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells.
Proc Natl Acad Sci U S A
; 107(28): 12605-10, 2010 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616015
12.
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586770
13.
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors.
MAbs
; 15(1): 2208697, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165468
14.
Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors.
Oncoimmunology
; 12(1): 2182058, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875551
15.
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab.
Exp Cell Res
; 317(9): 1255-60, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21419116
16.
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288466
17.
Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors.
Clin Cancer Res
; 27(5): 1452-1462, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262134
18.
TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors.
Mol Cancer Ther
; 20(1): 109-120, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203731
19.
Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen.
Cancer Immunol Immunother
; 59(8): 1197-209, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20309546
20.
Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies.
Cancer Cell Int
; 10: 44, 2010 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21044305